New diabetes clinical trial: Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery

Published on: April 30, 2020 at 09:30PM
Conditions:   Sellar and Suprasellar Masses;   Pituitary Tumor
Intervention:  
Sponsor:   Mayo Clinic
Recruiting
https://ift.tt/2YjuTFy